Q3 2025 Holdings
Filed 2025-11-14 | 59 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $81.7M | 1,750,000 | 7.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $61.2M | 2,250,000 | 5.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $57.0M | 1,200,000 | 5.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $47.5M | 5,575,000 | 4.3% |
| Revolution Medicines Inc(RVMD)Call | COM | 76155X100 | $46.7M | 1,000,000 | 4.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $38.0M | 3,250,000 | 3.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $35.9M | 375,000 | 3.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $35.8M | 4,050,000 | 3.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $35.2M | 415,000 | 3.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $33.0M | 15,150,000 | 3.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $31.8M | 1,227,300 | 2.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $31.4M | 3,208,875 | 2.8% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $30.9M | 850,000 | 2.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $30.4M | 2,400,000 | 2.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $29.7M | 450,000 | 2.7% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $27.5M | 3,655,000 | 2.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $26.4M | 200,000 | 2.4% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $26.1M | 600,000 | 2.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $23.8M | 850,000 | 2.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $22.9M | 935,000 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $22.6M | 1,000,000 | 2.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $22.5M | 625,000 | 2.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $20.2M | 200,000 | 1.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $20.1M | 2,200,000 | 1.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $19.9M | 300,000 | 1.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $19.7M | 1,450,000 | 1.8% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $17.8M | 1,130,000 | 1.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $17.5M | 300,000 | 1.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $14.2M | 250,000 | 1.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $14.0M | 100,000 | 1.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $13.5M | 165,000 | 1.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $13.4M | 850,000 | 1.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $12.7M | 525,000 | 1.1% |
| Ideaya Biosciences Inc(IDYA)Call | COM | 45166A102 | $12.2M | 450,000 | 1.1% |
| Janux Therapeutics Inc(JANX)Call | COM | 47103J105 | $12.2M | 500,000 | 1.1% |
| Larimar Therapeutics Inc(LRMR)Call | COM | 517125100 | $8.1M | 2,500,000 | 0.7% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $8.0M | 950,000 | 0.7% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $7.9M | 200,000 | 0.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.2M | 500,000 | 0.6% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $7.2M | 2,050,000 | 0.6% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $7.1M | 600,000 | 0.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $7.0M | 340,000 | 0.6% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $6.7M | 950,000 | 0.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $6.6M | 125,000 | 0.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $6.5M | 175,000 | 0.6% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $5.4M | 625,000 | 0.5% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $5.3M | 900,000 | 0.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.4M | 275,000 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $3.7M | 150,000 | 0.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.6M | 500,000 | 0.3% |